BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 16123959)

  • 1. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.
    Pawlik TM; Delman KA; Vauthey JN; Nagorney DM; Ng IO; Ikai I; Yamaoka Y; Belghiti J; Lauwers GY; Poon RT; Abdalla EK
    Liver Transpl; 2005 Sep; 11(9):1086-92. PubMed ID: 16123959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F; Angele MK; Rentsch M; Graeb C; Gerbes A; Löhrs U; Beuers U; Jauch KW
    Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor size predicts the biological behavior and influence of operative modalities in hepatocellular carcinoma.
    Kim SJ; Lee KK; Kim DG
    Hepatogastroenterology; 2010; 57(97):121-6. PubMed ID: 20422886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
    Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
    Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins.
    Matsuda M; Suzuki T; Kono H; Fujii H
    J Hepatobiliary Pancreat Surg; 2007; 14(3):289-96. PubMed ID: 17520205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.
    Kim BK; Han KH; Park YN; Park MS; Kim KS; Choi JS; Moon BS; Chon CY; Moon YM; Ahn SH
    J Surg Oncol; 2008 Mar; 97(3):246-52. PubMed ID: 18095300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of cell-cycle modulators to predict vascular invasion and recurrence after surgical treatment of hepatocellular carcinoma.
    Ramos E; Lladó L; Serrano T; Figueras A; Lastra R; Torras J; Figueras J; Rafecas A; Fabregat J
    Transplantation; 2006 Sep; 82(6):753-8. PubMed ID: 17006321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.
    Figueras J; Ibañez L; Ramos E; Jaurrieta E; Ortiz-de-Urbina J; Pardo F; Mir J; Loinaz C; Herrera L; López-Cillero P; Santoyo J
    Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH; Kim DJ; Han YS; Park JB; Choi GS; Kim SJ; Joh JW; Lee SK
    Dig Dis; 2007; 25(4):313-9. PubMed ID: 17960066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma.
    Cillo U; Vitale A; Brolese A; Zanus G; Neri D; Valmasoni M; Bonsignore P; Grigoletto F; Burra P; Farinati F; D'Amico DF
    J Surg Oncol; 2007 Mar; 95(3):213-20. PubMed ID: 17066432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases.
    Yeh CN; Lee WC; Jeng LB; Chen MF
    World J Surg; 2002 Sep; 26(9):1133-8. PubMed ID: 12209243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation.
    De Carlis L; Giacomoni A; Pirotta V; Lauterio A; Slim AO; Sammartino C; Cardillo M; Forti D
    J Am Coll Surg; 2003 Jun; 196(6):887-97. PubMed ID: 12788425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma.
    Liau KH; Ruo L; Shia J; Padela A; Gonen M; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; DeMatteo RP
    Cancer; 2005 Nov; 104(9):1948-55. PubMed ID: 16196045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.
    Yokoi H; Isaji S; Yamagiwa K; Tabata M; Nemoto A; Sakurai H; Usui M; Uemoto S
    J Hepatobiliary Pancreat Surg; 2006; 13(2):123-30. PubMed ID: 16547673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population.
    Schwarz RE; Smith DD
    Am J Surg; 2008 Jun; 195(6):829-36. PubMed ID: 18436176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.